Detalhe da pesquisa
1.
Aberrant Alternative Splicing in U2af1/Tet2 Double Mutant Mice Contributes to Major Hematological Phenotypes.
Int J Mol Sci
; 22(13)2021 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34203454
2.
CRISPR to fix bad blood: a new tool in basic and clinical hematology.
Haematologica
; 104(5): 881-893, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30923099
3.
Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome Mapping.
Cancers (Basel)
; 15(11)2023 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37297002
4.
Concurrent Zrsr2 mutation and Tet2 loss promote myelodysplastic neoplasm in mice.
Leukemia
; 36(10): 2509-2518, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36030305
5.
A Single-Run Next-Generation Sequencing (NGS) Assay for the Simultaneous Detection of Both Gene Mutations and Large Chromosomal Abnormalities in Patients with Myelodysplastic Syndromes (MDS) and Related Myeloid Neoplasms.
Cancers (Basel)
; 13(8)2021 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33919541
6.
Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma.
EMBO Mol Med
; 11(8): e10058, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31310053
7.
De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia.
Nat Commun
; 9(1): 1770, 2018 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29720585
8.
Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma.
EMBO Mol Med
; 12(1): e11749, 2020 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31916402
9.
FLT3N676K drives acute myeloid leukemia in a xenograft model of KMT2A-MLLT3 leukemogenesis.
Leukemia
; 33(9): 2310-2314, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30953031